Log In
Print this Print this

RG7880, UTTR1147A

  Manage Alerts
Collapse Summary General Information
Company Roche
Description Recombinant human protein
Molecular Target Interleukin-22 (IL-22)
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today